The strategic objectives of the Centre will be to:
- Provide essential infrastructure enabling researchers in ageing and dementia to compete globally by developing critical research strengths and collaborations.
- To develop and build capacity underpinning future increased grant capture, establishing essential research resources, novel skills and technologies
- Serve as a platform for internationally competitive multi-disciplinary and translational research that will have direct impact on health and well-being of the people of Wales
- Facilitate the translation of biological and psychosocial findings into clinical, diagnostic and social care practice within Wales.
- Interact with policy makers and practitioners disseminating research findings and establishing research priorities and collaborations
- Engage with the public to ensure that Centre research addresses the needs of the older people, people with dementia and carers as well as the public in general
- Develop and further business and clinical links, contributing to the health and wealth of Wales as well as enhancing the Life Science sector.
CADR is funded by Health and Care Research Wales, Welsh Government, and is a national, multi-faceted virtual organisation comprising several distinct elements. The Centre is led by Swansea University, in partnership with Cardiff University and Bangor University.
There will also be a number of Cross Cutting Themes which will underpin each of the work packages:
- Public Involvement & Engagement - development of a Wales wide CADR Involvement Group
- Social Care Aspects – Increased collaboration with social care practitioners
- Commercial/Industry Engagement & Collaboration
- NHS Services Professional Engagement and Collaboration
- Engagement with Welsh Government funded research infrastructure
- Communications, Publicity, Knowledge transfer
Read more about our work packages
Environments of Ageing
Psychosocial aspects of ageing
Social care aspects of ageing
Creativity and ageing
Resilience, well-being and ‘healthy’ ageing
Further Understanding the Genetics of Alzheimer’s disease
Translation of Genetic Findings into clinical and social impact
CRISPR/Cas9 Genome Editing to Model AD Risk Variants with Isogenic Pluripotent Stem Cells
Developing and evaluating interventions in dementia care